Author

Amy H. Ponsford

University of LiverpoolORCID 0000-0002-7178-7862Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

Benjamin J. HewittiD· 1 shared Christopher M. SandersoniD· 1 shared Hannah F. BotfieldiD· 1 shared James A. RobertsiD· 1 shared Jonathan PohiD· 1 shared Lisa J. HilliD· 1 shared Michael BatieiD· 1 shared Parveen SharmaiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

9 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPharmacology & Toxicology

Benjamin J. HewittORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Pharmacology & ToxicologyBiomedicine & PharmacotherapyPeer-reviewedDec 19, 2025

NRF2 upregulation by CDDO-Me protects AC16 human cardiomyocytes against doxorubicin-induced toxicity.

James A. Roberts, Michael Batie, Amy H. Ponsford…·Parveen Sharma

This study shows that CDDO-Me activates NRF2 to protect AC16 human cardiomyocytes from doxorubicin-induced toxicity by modulating p53 signaling, apoptosis, and ferroptosis.

DOI 10.1016/j.biopha.2025.118878

humanbulk RNA-seq

𝕏 PostBluesky